For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects

Podobne knjige/članki

• For Physicians Managing Voiding Dysfunction, Improving the Detection Rate of Early Prostate Cancer and Discrimination From Benign Prostatic Hyperplasia, in a Molecular Biomarker Aspects
  od: Won Tae Kim, et al.
  Izdano: (2019-03-01)
• Prostate Size Correlates with Fasting Blood Glucose in Non-Diabetic Benign Prostatic Hyperplasia Patients with Normal Testosterone Levels
  od: Kim, Won Tae, et al.
  Izdano: (2011)
• A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone
  od: Kang, Ho Won, et al.
  Izdano: (2020)
• Is There a Role for α-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia?
  od: Nitti, Victor W
  Izdano: (2005)
• Biomarkers for Benign Prostatic Hyperplasia Progression
  od: Cannon, Grant W., et al.
  Izdano: (2008)